Introduction {#Sec1}
============

Reporter genes are transcriptional fusions of genetic regulatory elements to reporter proteins that provide readily detectable signal outputs. Such reporter proteins include LacZ, chloramphenicol acetyltransferase, β-lactamase (Zlokarnik et al. [@CR34]), firefly luciferase (luc), bacterial luciferase (lux), and fluorescent proteins such as those derived from the green fluorescent protein of *Aequoria victoria* (e.g. GFP, EGFP, YFP) (Chalfie et al. [@CR2]; Cormack et al. [@CR3]; Andersen et al. [@CR1]; Miyawaki et al. [@CR23]; also reviewed in van der Meer et al. [@CR21]). These gene fusions have been used in detecting xenobiotic compounds (King et al. [@CR16]; DiGrazia et al. [@CR4]), monitoring performance of synthetic gene circuits (Elowitz and Leibler [@CR6]; Hasty et al. [@CR11]; Gardner et al. [@CR8]), in genome-wide expression arrays (Van Dyk et al. [@CR31]), as well as in in vivo imaging studies (Xiong et al. [@CR33]; Kadurugamuwa et al. [@CR13]; Kuklin et al. [@CR17]; Doyle et al. [@CR5]).

While these reporter proteins have numerous applications, all except the bacterial luciferase system require the additional input of reactants or UV light. The bioluminescent gene cassette comprising the *lux* system was originally isolated from *Vibrio fischeri* (Engebrecht et al. [@CR7]). Later, more thermally stable versions of *lux* were isolated from *Photorhabdus* (*Xenorhabus*) *luminescens* and other species (Schmidt et al. [@CR26]; Szittner and Meighen [@CR27]). In these systems, the heterodimeric bacterial luciferase comprised of LuxAB oxidizes an aliphatic aldehyde substrate and FMNH~2~ in the presence of diatomic oxygen to release a photon of light at a wavelength of ∼490 nm (reviewed in Meighen ([@CR22])). The remainder of the cassette consisting of the *luxC*, *D* and *E* genes, encode proteins that are responsible for generating and recycling the aldehyde substrate for the reaction.

Another major problem with most reporter systems are the relatively long half-lives of the reporter proteins, which complicate the detection and monitoring of dynamic changes in gene regulation at the transcriptional level. To address these issues, modifications to the protein coding sequences of some of these reporter systems have been made to include amino acids sequences that are recognized by host protein degradation machinery resulting in more rapid turnover of the reporter protein (Andersen et al. [@CR1]; Mateus and Avery [@CR20]; Li et al. [@CR19]; Triccas et al. [@CR28]). Similar tactics have been employed in the engineering of synthetic gene constructs such as the Repressilator (Elowitz and Leibler [@CR6]).

To build on the existing utility of the bacterial *lux* reporter system, we modified each of the individual *luxA* and *luxB* monomers of the bacterial luciferase holoenzyme and tested them both individually and in combination. The modification employed a naturally occurring protein degradation pathway in *Escherichia coli*. This system, used for removing peptides synthesized from truncated mRNA, involves the addition of an 11-amino acid carboxy-terminal peptide tag (AANDENYALAA) and requires the SsrA RNA (Tu et al. [@CR29]; Keiler et al. [@CR14]). Cytoplasmic proteins containing the tag are rapidly degraded by the ClpP protease in conjunction with either ClpA or ClpX (Gottesman et al. [@CR9]; Weber-Ban et al. [@CR32]; Kim et al. [@CR15]). In addition, the essential protease HflB may also play a role in degradation (Herman et al. [@CR12]). Direct modification of a DNA sequence to encode the 11-amino acid SsrA tag on the 3′ end of the gene to be expressed on the carboxy-terminus of a protein has been previously shown to result in rapid degradation of proteins within the cell (Andersen et al. [@CR1]; Elowitz and Leibler [@CR6]; Herman et al. [@CR12]). Furthermore, alteration of the last three amino acids on the tag has been used to alter the recognition specificity of the proteases, thereby generating a variety of protein half-lives of intermediate lengths (Andersen et al. [@CR1]). Addition of the SsrA tag has also been shown to result in short half-life GFP variants in *Pseudomonas* and *Mycobacterium* species (Andersen et al. [@CR1]; Triccas et al. [@CR28]).

We have employed a similar approach for the modification of the bacterial luciferase holoenzyme and show that modification of a single monomer of the holoenzyme, LuxA, is sufficient for altering the functional half-life of the holoenzyme. Conversely, modification of the LuxB monomer alone neither impacts the performance of the holoenzyme nor results in decay of the bioluminescent signal. Based on these results, additional variants of *luxA* were generated containing modifications of the last three amino acids of the tag, and their half-lives were found to range between that containing the native SsrA tag (abbreviated here as -laa) and the wild type holoenzyme. Finally, the carboxy-terminal tags were cloned into an existing plasmid in a manner that should facilitate retrofitting of other *P. luminescenslux*-based reporters for the monitoring of rapid changes in transcription, or inclusion into synthetic gene circuits where dynamic signal performance is critical.

Materials and methods {#Sec2}
=====================

Genetic constructs {#Sec3}
------------------

Wild type and modified variants of the *luxA* and *luxB* genes were amplified by PCR from a vector containing the *P. luminescenslux CDABE* operon (pCDABE) using the primers listed in Table [1](#Tab1){ref-type="table"}. Abbreviations for the tag (e.g. -*aav*) are indicated in the name of the construct after the gene being affected. Wild type *luxAB* and *luxABaav* were amplified by PCR, gel purified, and cloned into the TOPO-TA cloning vector pCR2.1 (Invitrogen) per the manufacturer's instructions. For *luxA* variants, *luxBaav*, and wild-type *luxB*, the genes were independently amplified and cloned. The intergenic sequence upstream of the ribosomal binding site between *luxA* and *luxB* was modified to create a unique *Xma*I site and facilitate subsequent construction. The *luxA* variants were digested overnight with *Xma*I and *Xba*I and ligated upstream of the *luxB* or *luxBaav* genes in pCR2.1. The wild type *luxAB* and the newly assembled variants were then each double digested overnight from their respective TA-cloning vectors with *BamH*I and *Kpn*I, gel purified, and directionally cloned in place of the *GFPasv* gene of the repressilator reporter plasmid (Elowitz and Leibler [@CR6]). For insertion of the tagged *luxA* into an existing full *lux* cassette, the appropriate primary construct was subsequently digested internal to both *luxA* (AgeI) and *luxB* (BfuAI) and the tag-bearing fragment was directionally cloned into the similarly digested pCDABE. Cloning reactions were conducted at room temperature for 10 min and included: 100 ng vector DNA, a 2:1 molar ratio of insert to vector DNA, 4 U of T4 DNA ligase (Fisher Scientific, Pittsburgh, PA) and 2 × LigaFast rapid ligation buffer (Promega, Madison, WI) in 25--35 μ l reactions. Restriction enzymes were purchased from New England Biolabs (Beverly, MA), and all digestions were conducted using 5 U of each enzyme and incubated overnight at 37°C except in the case of *BfuA*I, in which digestion was incubated for 4 h at 50°C, followed by transfer to 37°C and the addition of *Age*I.Table 1Primers used in this studyUnique restriction sites used in the final assembly are underlined. Start and stop codons and pertinent amino acids are indicated above the respective sequences

Strains and growth conditions {#Sec4}
-----------------------------

Strains used in this study are listed in Table [2](#Tab2){ref-type="table"}. Luria-Bertani media (Sambrook et al. [@CR25]) was used for all experiments with 50 μ g/ml kanamycin as necessary, and incubated at 37°C with shaking at 100 r.p.m. when appropriate.Table 2Strains and plasmids used in this workNamePropertiesSource*E. coli* TOP10 and TOP10F′Cloning and expression strains. Expression from the lac promoter in F′ cells is IPTG inducibleInvitrogen (Carlsbad, CA)pCR2.1TOPO TA Cloning vector. Am^R^, Km^R^InvitrogenpCDABEpCRXL (Invitrogen) containing PCR-amplified *luxCDABE* from *Photorhabdus luminescens*Gift from J. SanseverinopZE21-GFPasvKm^r^; Plasmid containing short half-life GFPasv constitutively expressed from the P~Ltet01~ promoterElowitz and LeiblerpABpZE21-GFPasv with the wild-type *luxAB* of *P. luminescens* cloned in place of *GFPasv*This workpABaavSimilar to pAB using the alternative tag AANDENYAAAV translationally fused to *luxB* by PCRThis workpAaavBaavSimilar to pAB using the *luxA* and *luxB* genes each modified to include the gene sequence for the 11-amino acid carboxy-terminal tag AANDENYAAAVThis workpAaavBpAB containing the *luxA* gene modified to include the gene sequence of the 11-amino acid carboxy-terminal tag AANDENYAAAV, and the wild type *luxB*This workpAlaaBSimilar to pAaavB using the alternative tag AANDENYALAAThis workpAasvBSimilar to pAaavB using the alternative tag AANDENYAASVThis workpCDAasvBEpCDABE containing the 3′ end of the modified *luxA* gene and the 5′ end of *luxB* from pAsvBThis workpCDAaavBEAs in pCDAasvBE but using pAaavBThis workpCDAlaaBEAs in pCDAasvBE but using pAlaaBThis work

Bioluminescence assays {#Sec5}
----------------------

Overnight cultures of the four variants of *luxAB* and a negative control carrying the parent vector with the gene for destabilized green fluorescent protein, *Gfpasv*, were transferred into triplicate tubes of fresh LB medium containing 50μg/ml kanamycin. Cultures were then grown to an optical density at 546 nm (OD~546~) of ∼0.6. Initial bioluminescence measurements were made at *t* = 0 as described below. Subsequently, rifampicin (150 μg/ml) and tetracycline (30 μg/ml) were added to all cultures to block transcription and translation, respectively. For bioluminescence measurements, 1-ml samples were taken immediately (*t* = 0) and at 30 min intervals thereafter and assayed for optical density at 546 nm (OD~546~) and bioluminescence. OD~546~ was measured using a Beckman DU-640B spectrophotometer. Bioluminescence was assayed by first adding 10 μl of *N*-decanal (Sigma, St. Louis, MO) to the 1-ml samples, inverting 10 times, and measuring light with a SDI Deltatox handheld luminometer. Three light measurements were taken in rapid succession and these values were averaged for each sample. Error bars represent the standard deviations between the averages of three independent samples.

Variants of *luxA* containing the -*laa*, -*aav* and -*asv* tags were chosen for further analysis. Plasmids containing the constructs were digested with *Age*I and *BfuA*I, gel purified, and cloned as described above into the similarly treated pCDABE. The latter contains the entire *P. luminescens lux* operon under the control of the *lac* promoter in the multi-copy pCR-XL-TOPO vector (Invitrogen). Resulting plasmids were then transformed into *E. coli* TOP10 F′ cells (Invitrogen) for IPTG-inducible expression. For induction experiments, overnight cultures of cells grown in LB with 0.2 mM IPTG were diluted 1:5 in the same, fresh, preheated medium, and incubated at 37°C until reaching an OD~600~ of 0.15--0.2 (approximately 4 h). Cells were subsequently collected by centrifugation, washed with fresh M9 containing 100 mM leucine medium without inducer, and incubated in M9 + leucine medium at 37°C. One milliliter samples were removed every 20 min for bioluminescent measurements using a SDI Deltatox handheld luminometer. Three measurements were taken in rapid succession for each sample and their values were averaged, and three independent replicates were performed for each variant.

Results and discussion {#Sec6}
======================

Bioluminescence measurements of cells harboring plasmids containing the wild type *luxAB* genes of *P. luminescens* behind a constitutive promoter were compared to those of *luxA* and *luxB* variants containing carboxy-terminal tags designed to accelerate degradation of the protein(s) within the cell. Assays using constructs containing only *luxA* and *luxB* (i.e. which lack *luxC*, *D*, and *E* and hence are unable to produce the substrate) were conducted by adding antibiotics to block transcription and translation (rifampicin and tetracycline, respectively), followed by monitoring bioluminescence with the addition of aldehyde over time. As shown in Fig. [1](#Fig1){ref-type="fig"}, modification of the LuxB protein did not result in a decrease of bioluminescence. Bioluminescence in this variant was found to remain relatively constant similar to the wild type over the course of the experiments. Addition of the same -*aav* tag (encoding AANDENYAAAV) to the *luxA* gene resulted in a rapid decrease in bioluminescence after time *t*~0~. An even more dramatic decrease in bioluminescence was observed when both LuxA and LuxB included the -aav tag. Interestingly, the clone containing *luxABaav* (wild type *luxA* with modified *luxB*) appeared to produce more light than did the wild-type *luxAB*. Since this result was reproducible within the experimental parameters (Fig. [1](#Fig1){ref-type="fig"}) yet inconsistent with those generated in the absence of antibiotics (Table [3](#Tab3){ref-type="table"}), it is believed that this result is an experimental artifact.Fig. 1Total bioluminescence (arbitrary units) of clones containing wild type *luxAB*, and *luxABaav* (left axis), and *luxAaavB*, *luxAaavBaav* and the negative control (right axis) over time following the addition of tetracycline and rifampicin (*t* = 0). Measurements were made following the addition of *N*-decanal as described in the "Materials and methods". Values are averages of triplicate samples with error bars representing standard deviations among the replicates. The negative control contains the parent plasmid without the luciferase genesTable 3Comparison of total (arbitrary units) and relative (% w.t.) bioluminescence output from 1-ml samples of mid-log cultures (OD~546~ = ∼0.4) containing the indicated plasmids after addition of 10 μ l *N*-decanalPlasmidTotal bioluminescenceStd. dev.% w.t.Est. half-lifepAaavBaav2,51077.560.13N.D.pAlaaB11,998713.50.6146pAaavB17,0571,5240.8748pAsvB632,2609,42432.21145pABaav1,994,75179,169101.64 \> 240pAB1,962,650121,346100.00 \> 240Negative control50442N.D.N.A.Values for half-lives are in minutes. N.D. = not determined; N.A. = not applicable. Negative control consisted of the parent strain containing no plasmid

In the unregulated case where enzyme was allowed to accumulate to a steady state level dependent upon the relative half-lives of their luciferases, mid-log cultures of pLuxAaavB produced approximately 100-fold less bioluminescence than the wild-type (Table [3](#Tab3){ref-type="table"}). The double modified holoenzyme produced bioluminescence nearly 800-fold less than the wild type (Table [3](#Tab3){ref-type="table"}).

To determine if the drop in bioluminescence output could be attributed solely to interference of the carboxy-terminal tag to enzymatic activity, two additional constructs were made with predicted half-lives greater (-*asv* encoding AANDENYAASV) and lesser (-*laa* encoding AANDENYALAA) than those predicted for -*aav*. Total bioluminescent output for all of these constructs is shown in Table [3](#Tab3){ref-type="table"}.

Variants of *luxA* were subsequently cloned into a vector containing the entire *lux* operon by restriction digestion interior to each of the *luxA* and *B* genes and replacement of the wild type fragment with fragments containing the modified *luxA* gene. Results of experiments on luminescent decay following the removal of inducer (isopropyl-β-[d]{.smallcaps}-thiogalactopyranoside; IPTG) are shown in Fig. [2](#Fig2){ref-type="fig"}.Fig. 2Relative bioluminescence over time for *luxA* variants contained within the entire *lux* cassette following removal of the IPTG inducer

Conclusions {#Sec7}
===========

The results for variants containing the modified *luxA* gene are consistent with those previously reported by Anderson et al. (Andersen et al. [@CR1]) for GFP, and indicate that the single modification of this monomer is sufficient to result in decreased functional half-life of the heterodimeric holoenzyme (Fig. [1](#Fig1){ref-type="fig"} and Table [3](#Tab3){ref-type="table"}). This modification may impact enzymatic activity of the holoenzyme since the carboxy-terminus of LuxA is thought to be involved in substrate binding (Valkova et al. [@CR30]). However, bioluminescence outputs for all variants were readily detectable under our test conditions. Interestingly, modification of the LuxB monomer alone neither decreased peak bioluminescence nor resulted in decay of bioluminescence over time when compared to the wild type. Modification of both *luxA* and *luxB* genes to include the -*aav* tag (*luxAaavBaav*), however, resulted in lower total bioluminescence than modification of *luxA* alone (Fig. [1](#Fig1){ref-type="fig"}). These results suggest that the carboxy-terminus of LuxB may be protected in the heteroduplex of the holoenzyme and inaccessible to cellular proteases, but its release following the degradation of LuxA may facilitate its subsequent degradation and account for the reduced bioluminescence of the double-modified variant.

Modification of protein half-lives in eukaryotic proteins by the carboxy-terminal additions of the PEST-rich region from the G~1~ cyclin Cln2 and the degradation domain of mouse ornithine decarboxylase have been used to generate destabilized variants of GFP in yeast and mammalian systems (Mateus and Avery [@CR20]; Li et al. [@CR19]), as well as firefly luciferase (Leclerc et al. [@CR18]). Such an approach could also be applied to the *luxA* and *luxB* genes, which have been codon-optimized for expression in eukaryotic systems (Gupta et al. [@CR10]; Patterson et al. [@CR24]). Furthermore, the approach taken here in which the insertion of the *luxA-tag-B* fragment into an existing construct containing the entire *P. luminescenslux* cassette should be widely applicable to a number of existing *lux*-based reporter systems, and will allow relatively simple retrofitting of those constructs to generate short half-life variants for dynamic monitoring of changes in gene expression in reporter gene transcription, in vivo imaging, and synthetic biology applications.
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